1-17 of 17
Chelo Rayón
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcome Of 151 Patients With Relapsed APL Receiving Second-Line With Chemotherapy Or Arsenic Trioxide-Based Regimens

Pau Montesinos, David Martínez-Cuadrón, Concha Rivas, Salut Brunet, MD, PhD, José David González-San Miguel, Vicente Rubio, Cristina Pérez, Félix Manso, Pedro Sánchez-Godoy, Lourdes Escoda, Elena Amutio, Mark Zijlmans, MD, Mar Tormo, MD, Marcos González, MD, Chelo Rayón, María José Sayas, Josep-Maria Ribera, MD, PhD, Guillermo Deben, José Hernández-Martín, Jordi Esteve, MD, PhD, Edo Vellenga, MD, PhD, Miguel Sanz
Journal: Blood
Blood (2013) 122 (21): 3922.
https://doi.org/10.1182/blood.V122.21.3922.3922
Published: 2013
Journal Articles

Intensive (2+5) Or Semi-Intensive (FLUGA) Chemotherapy For Patients With Acute Myeloid Leukemia Who Are 70 Years Of Age Or Older

Pau Montesinos, David Martínez-Cuadrón, Esperanza Lavilla, Joaquín Díaz-Mediavilla, Pilar Herrera, García Raimundo, Juan Bergua, Pascual Fernandez, Maria Pedreño, Alfons Serrano, Lorenzo Algarra, Edelmira Martí, Chelo Rayón, Francisco Jaramillo, Manuel Perez-Encinas, Andrea Galego, Rosalía Riaza, Mª Pilar Martínez Sánchez, Adriana Simiele, Claudia Sossa, Rebeca Rodríguez-Veiga, José Luís Piñana, Miguel Sanz
Journal: Blood
Blood (2013) 122 (21): 2687.
https://doi.org/10.1182/blood.V122.21.2687.2687
Published: 2013
Journal Articles

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all- trans retinoic acid and anthracycline-based regimens

Clinical Trials & Observations
Pau Montesinos, Chelo Rayón, Edo Vellenga, Salut Brunet, José González, Marcos González, Aleksandra Holowiecka, Jordi Esteve, Juan Bergua, José D. González, Concha Rivas, Mar Tormo, Vicente Rubio, Javier Bueno, Félix Manso, Gustavo Milone, Javier de la Serna, Inmaculada Pérez, Manuel Pérez-Encinas, Isabel Krsnik, Josep M. Ribera, Lourdes Escoda, Bob Lowenberg, Miguel A. Sanz, on behalf of the PETHEMA and HOVON Groups
Journal: Blood
Blood (2011) 117 (6): 1799–1805.
https://doi.org/10.1182/blood-2010-04-277434
Published: 2011
Journal Articles

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Clinical Trials & Observations
Martin S. Tallman, Haesook T. Kim, Pau Montesinos, Frederick R. Appelbaum, Javier de la Serna, John M. Bennett, Guillermo Deben, Clara D. Bloomfield, Jose Gonzalez, James H. Feusner, Marcos Gonzalez, Robert Gallagher, Jose D. Gonzalez-San Miguel, Richard A. Larson, Gustavo Milone, Elisabeth Paietta, Chelo Rayon, Jacob M. Rowe, Concha Rivas, Charles A. Schiffer, Edo Vellenga, Lois Shepherd, James L. Slack, Peter H. Wiernik, Cheryl L. Willman, Miguel A. Sanz
Journal: Blood
Blood (2010) 116 (25): 5650–5659.
https://doi.org/10.1182/blood-2010-06-288613
Published: 2010
Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia based on all- trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

CME
Miguel A. Sanz, Pau Montesinos, Chelo Rayón, Alexandra Holowiecka, Javier de la Serna, Gustavo Milone, Elena de Lisa, Salut Brunet, Vicente Rubio, José M. Ribera, Concha Rivas, Isabel Krsnik, Juan Bergua, José González, Joaquín Díaz-Mediavilla, Rafael Rojas, Félix Manso, Gert Ossenkoppele, José D. González, Bob Lowenberg
Journal: Blood
Blood (2010) 115 (25): 5137–5146.
https://doi.org/10.1182/blood-2010-01-266007
Published: 2010
Journal Articles

Very Long Term Outcome of Acute Promyelocytic Leukemia After Treatment with All Trans Retinoic Acid and Chemotherapy: The European APL Group Experience.

Lionel Ades, MD, Agnes Guerci, MD, PhD, Emmanuel Raffoux, MD, Miguel Sanz, MD, PhD, Patrice Chevallier, MD, Simona Lapusan, MD, Christian Recher, MD, PhD, Xavier Thomas, MD, PhD, Chelo Rayon, MD, Sylvie Castaigne, MD, PhD, Olivier Tournilhac, MD, PhD, Stephane de Botton, MD, PhD, Norbert Ifrah, MD, PhD, Jean-Yves Cahn, MD, PhD, Eric Solary, MD, PhD, Claude Gardin, MD, Nathalie Fegeux, MD, Dominique Bordessoule, MD, PhD, Augustin Ferrant, MD, PhD, Sandrine Meyer, MD, PhD, Norbert Vey, MD, PhD, Herve Dombret, MD, PhD, Laurent Degos, MD, PhD, Sylvie Chevret, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2088.
https://doi.org/10.1182/blood.V114.22.2088.2088
Published: 2009
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) in the Elderly: A Joint Analysis of the French -Belgian-Swiss and PETHEMA Groups.

Lionel Ades, MD, Pau Montesinos, MD, Sylvie Chevret, PhD, Edo Vellenga, MD, Emmanuel Raffoux, MD, Chelo Rayon, MD, Joaquim Díaz-Mediavilla, Xavier Thomas, MD, PhD, Patrice Chevallier, MD, Concha Rivas, Agnes Guerci, MD, PhD, Elena Amutio, MD, Francoise Huguet, MD, Jesus Arias, MD, Norbert Vey, MD, PhD, Guillermo Deben, MD, Sandrine Meyer, MD, PhD, Andres Novo, MD, Augustin Ferrant, MD, PhD, Juan Bergua, MD, Mathieu Resche Rigon, PhD, Javier de la Serna, MD, Herve Dombret, MD, PhD, Sylvie Castaigne, MD, PhD, Pierre Fenaux, MD, PhD, Miguel A. Sanz, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 845.
https://doi.org/10.1182/blood.V114.22.845.845
Published: 2009
Journal Articles

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all- trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

Clinical Trials & Observations
Pau Montesinos, Juan M. Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Angel León, Jordi Esteve, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, Miguel A. Sanz
Journal: Blood
Blood (2009) 113 (4): 775–783.
https://doi.org/10.1182/blood-2008-07-168617
Published: 2009
Journal Articles

Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia

Pau Montesinos, MD, Edo Vellenga, Aleksandra Holowiecka, Chelo Rayon, Gustavo Milone, Javier de la Serna, Angel Leon, Juan Bergua, Concha Rivas, Jose Gonzalez, Jordi Esteve, Miguel A. Sanz, MD, PhD, On behalf of the PETHEMA, HOVON, PALG, and GATLA cooperative groups
Journal: Blood
Blood (2008) 112 (11): 2992.
https://doi.org/10.1182/blood.V112.11.2992.2992
Published: 2008
Journal Articles

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All- Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients

Miguel A. Sanz, MD, PhD, Pau Montesinos, Aleksandra Holowiecka, Gustavo Milone, Chelo Rayon, Elena de Lisa, Javier de la Serna, Salut Brunet, Angel Leon, Isabel Krsnik, Concha Rivas, Jose M. Ribera, Jose Gonzalez, Joaquín Díaz- Mediavilla, Javier Bueno, Jose David Gonzalez, Juan Bergua, Marcos Gonzalez
Journal: Blood
Blood (2008) 112 (11): 138.
https://doi.org/10.1182/blood.V112.11.138.138
Published: 2008
Journal Articles

Impact of ATRA Duration during the Induction Treatment of Newly Diagnosed APL

Sylvain Thepot, Claude Gardin, Sylvie Chevret, Stephane de Botton, Emmanuel Raffoux, Agnes Guerci, Xavier Thomas, Arnaud Pigneux, Norbert Vey, Thierry Lamy, Francoise Huguet, Anne Vekhoff, Sandrine Meyer, Chelo Rayon, Thomas Pabst, Patrice Chevalier, Frederic Maloisel, Eric Deconinck, Augustin Ferrant, Dominique Bron, Herve Dombret, Nathalie Fegueux, Javier de la Serna, jean-Yves Cahn, Norbert Ifrah, Miguel A Sanz, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2008) 112 (11): 139.
https://doi.org/10.1182/blood.V112.11.139.139
Published: 2008
Journal Articles

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

Clinical Trials & Observations
Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody, Angel León, Jordi Esteve, Juan M. Bergua, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, Miguel A. Sanz
Journal: Blood
Blood (2008) 111 (7): 3395–3402.
https://doi.org/10.1182/blood-2007-07-100669
Published: 2008
Journal Articles

Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia.

Pau Montesinos, MD, Jose D. Gonzalez, PHD, Chelo Rayon, PHD, Javier de la Serna, PHD, Juan Bergua, PHD, Jordi Esteve, PHD, Mar Tormo, PHD, Edo Vellenga, PHD, Elena Amutio, PHD, Guillermo Deben, PHD, Miguel Sanz, PHD
Journal: Blood
Blood (2007) 110 (11): 1838.
https://doi.org/10.1182/blood.V110.11.1838.1838
Published: 2007
Journal Articles

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.

Miguel A. Sanz, PhD, Pau Montesinos, MD, Edo Vellenga, PhD, Chelo Rayon, PhD, Ricardo Parody, PhD, Javier de la Serna, PhD, Juan Bergua, PhD, Angel Leon, PhD, Silvia Negri, PhD, Concha Rivas, PhD, Salut Brunet, PhD, Marcos Gonzalez, PhD, Jordi Esteve, PhD, Bob Lowenberg, PhD
Journal: Blood
Blood (2007) 110 (11): 590.
https://doi.org/10.1182/blood.V110.11.590.590
Published: 2007
Journal Articles

Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Reinforced Anthracycline Monochemotherapy.

Pau Montesinos, MD, Jose D. Gonzalez, PHD, Edo Vellenga, PHD, Chelo Rayon, PHD, Ricardo Parody, PHD, Angel Leon, PHD, Jordi Esteve, PHD, Juan Bergua, PHD, Gustavo Milone, PHD, Miguel A. Sanz, PHD
Journal: Blood
Blood (2007) 110 (11): 592.
https://doi.org/10.1182/blood.V110.11.592.592
Published: 2007
Journal Articles

Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.

Martin S. Tallman, MD, Haesook T. Kim, PhD, Charles A. Schiffer, MD, Frederick R. Appelbaum, MD, James H. Feusner, MD, Angela K. Ogden, MD, Lois Shepherd, MD, Cheryl L. Willman, MD, Clara D. Bloomfield, MD, Jacob M. Rowe, MD, Richard A. Larson, MD, Peter H. Wiernik, MD, Guillermo Martin, MD, Chelo Rayon, MD, Javier de la Serna, MD, Concha Rivas, MD, Jose D. Gonzalez-San Miguel, MD, Guillermo Deben, MD, Miguel A. Sanz, MD
Journal: Blood
Blood (2004) 104 (11): 394.
https://doi.org/10.1182/blood.V104.11.394.394
Published: 2004
Journal Articles

Causes of Induction Failure in Newly Diagnosed Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Idarubicin (AIDA).

Javier de la Serna, MD, Guillermo Martin, MD, Edo Vellenga, MD, Chelo Rayon, MD, Concha Rivas, MD, Guillermo Deben, MD, Marcos Gonzalez, MD, Mar Tormo, MD, Juan Bergua, MD, Jaoquin Diaz-Mediavilla, MD, Angel Leon, MD, Jordi Esteve, MD, Ricardo Parody, MD, Elena Amutio, MD, Jose D. Gonzalez, MD, Silvia Negri, MD, Francisco J. Capote, MD, Javier Bueno, MD, Manuel Perez-Encina, MD, Andres Novo, MD, Antonia Rodriguez, MD, Miguel A. Sanz, MD
Journal: Blood
Blood (2004) 104 (11): 887.
https://doi.org/10.1182/blood.V104.11.887.887
Published: 2004